Related references
Note: Only part of the references are listed.RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy
Rene Alvarez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Evaluation of the safety, tolerability and pharmacokinetics of ALN-RSV01, a novel RNAi antiviral therapeutic directed against respiratory syncytial virus (RSV)
John DeVincenzo et al.
ANTIVIRAL RESEARCH (2008)
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Mark E. Kleinman et al.
NATURE (2008)
Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits
M. DiFiglia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Palivizumab and the prevention of respiratory syncytial virus illness in pediatric patients with congenital heart disease
Timothy F. Feltes et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2007)
Serum antibody decay in adults following natural respiratory syncytial virus infection
Ann R. Falsey et al.
JOURNAL OF MEDICAL VIROLOGY (2006)
RNAi-mediated gene silencing in non-human primates
TS Zimmermann et al.
NATURE (2006)
Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs
DV Morrissey et al.
NATURE BIOTECHNOLOGY (2005)
Respiratory syncytial virus load predicts disease severity in previously healthy infants
JP DeVincenzo et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus
SM Perkins et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Respiratory syncytial virus infection in elderly and high-risk adults
AR Falsey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model
SQ Harper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7
V Hornung et al.
NATURE MEDICINE (2005)
Inhibition of respiratory viruses by nasally administered siRNA
V Bitko et al.
NATURE MEDICINE (2005)
Experimental infection of humans with A2 respiratory syncytial virus
FEH Lee et al.
ANTIVIRAL RESEARCH (2004)
Natural infection of infants with respiratory syncytial virus subgroups A and B: A study of frequency, disease severity, and viral load
JP DeVincenzo
PEDIATRIC RESEARCH (2004)
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
J Soutschek et al.
NATURE (2004)
Mortality associated with influenza and respiratory syncytial virus in the United States
WW Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Medical progress - Respiratory syncytial virus and parainfluenza virus.
CB Hall
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
SM Elbashir et al.
NATURE (2001)
Nasal quantity of respiratory syncytial virus correlates with disease severity in hospitalized infants
SC Buckingham et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2000)
Specific interference with gene function by double-stranded RNA in early mouse development
F Wianny et al.
NATURE CELL BIOLOGY (2000)
Share Paper
